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Haloduracin is a bacterially produced antibiotic system of two alkali-stable peptides (Hala and Halb) that
have extensive posttranslational modifications, including lanthionine rings. Now, Cooper et al. (2008) revise
the structure of Halb and demonstrate that some of the lanthionine rings are not essential for bioactivity.
Bacterial infections are a growing concern
in human health, due to food-borne
illnesses as well as infectious diseases
that show resistance to currently available
antibiotics. The emergence of virulent
strains such as methicillin-resistant
Staphylococcus aureus (MRSA), vanco-
mycin-resistant Staphylococcus aureus
(VRSA), and vancomycin-resistant En-
terococci (VRE) has led to the outbreak
of many hospital-acquired infections, of-
ten with life-threatening results. Common
food pathogens, including Escherichia
coli, Listeria monocytogenes, and Salmo-
nella typhimurium, can cause gastrointes-
tinal illnesses upon ingestion of contami-
nated food. These issues have prompted
scientists to search for new antimicrobial
agents to fight bacterial infections. In
this line of research, antimicrobial pep-
tides have gained attention as a promising
class of possible therapeutic agents (Cot-
ter et al., 2005).
Lantibiotics are a class of antimicrobial
peptides producedbyGram-positive bac-
teria and display activity against other
Gram-positive organisms. Thesepeptides
are ribosomally synthesized, undergo ex-
tensive posttranslational modifications,
and, upon cleavage of a leader peptide,
yield the biologically active mature pep-
tides (Chatterjee et al., 2005; Willey and
vanderDonk, 2007). Lantibiotics are char-
acterized by the presence of unusual
amino acids, such as lanthionine (Lan),
b-methyllanthionine (MeLan), 2,3-didehy-
droalanine (Dha), and didehydrobutyrine
(Dhb) (Chatterjee et al., 2005; Willey and
van der Donk, 2007). Nisin, the oldest
and most-studied lantibiotic, has been
used in the preservation of meat and dairy
products for over 40 years without the ap-
pearance of significant resistance (Cotter
et al., 2005). Studies have shown that
some lantibiotics exert a dual mode of ac-
tion against sensitive strains. They bind to
lipid II, a precursor for the biosynthesis of
bacterial cell wall, thereby interfering with
bacterial growth. In addition, some have
a pore forming ability that leads to the
leakage of cellular contents and subse-
quent cell death (Wiedemann et al.,
2006). Lantibiotics are usually orders of
magnitudemore potent than conventional
small-molecule antibiotics, such as peni-
cillin and vancomycin, and are often active
against virulent strains such asMRSA and
VRE (Cotter et al., 2005). The low toxicity
of many lantibiotics toward mammals
makes them an attractive class of com-
pounds for food preservation and clinical
applications (Cotter et al., 2005).
Two-component lantibiotic systems,
such as lacticin 3147 (Ryan et al., 1996),
consist of two structurally distinct pep-
tides that are secreted by a single pro-
ducer strain. The two peptides act
synergistically to exert bioactivity against
sensitive strains (Garneau et al., 2002;
Ryan et al., 1996). It is believed that the
mode of action of the two-component
lantibiotics resembles that of the one-
component lantibiotics (Wiedemann
et al., 2006). The 3-dimensional structure
of these peptides is believed to be crucial
for bioactivity. Their conformation is gov-
erned not only by the amino acid se-
quence, but also by the presence of the
lanthionine rings. Current research exam-
ining the biosynthesis and the functional
role of posttranslational modifications in
lantibiotics provides insights into how
these antimicrobial peptides interact with
target cells at the molecular level (Cotter
et al., 2006). Ultimately, this knowledge
may allow researchers to develop simpler
structures through biological or synthetic
means that retain bioactivity.
Recently, a novel two-component lanti-
biotic, haloduracin, was isolated from the
alkaliphile Bacillus halodurans C-125
(Lawton et al., 2007; McClerren et al.,
2006). The mature peptides have been
named haloduracin a (Hala) and halodura-
cin b (Halb) (Figure 1). Interestingly, B. hal-
odurans grows at pH > 9.0, indicating that
haloduracin is stable under alkaline condi-
tions (McClerren et al., 2006). This gives
haloduracin an important advantage
over other known lantibiotics, which are
often unstable at pH > 7.
In this issue of Chemistry & Biology,
Cooper et al. (2008) have reported the
structure-activity relationship (SAR) stud-
ies of haloduracin. This work has demon-
strated the efficacy and benefits of in vitro
biosynthetic methods for mutational
studies of lantibiotics. After preparing
a number of analogs of Hala and Halb pre-
cursors via mutagenesis, various in vitro
enzymatic transformations were per-
formed to investigate the dehydration
and cyclization modifications of these an-
alogs. This led the authors to revise the
initially proposed structure of Halb and
also allowed them to explore the impor-
tance of particular amino acid residues
and structural modifications for activity.
During their study, Cooper et al. (2008)
systematically mutated the serine(Ser)/
threonine(Thr) residues to alanine and ex-
amined the dehydration pattern of the
mutants. In Halb, it was initially believed,
by sequence homology to other lantibiot-
ics, that Thr18 escaped dehydration,
whereas Ser22 was dehydrated to Dha
(McClerren et al., 2006). However, the
mutational studies have revealed that ac-
tually Ser22 escaped dehydration and
Thr18 is dehydrated to Dhb. These results
led to the revision of the originally pro-
posed structure for Halb and highlighted
a limitation of the initial approach to halo-
duracin structural analysis. As the authors
suggested, the use of sequence homol-
ogy alone is not enough to allow for the
structural elucidation of novel lantibiotics
(Cooper et al., 2008).
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portance of the thioether rings of Hala and
Halb. By sequentially mutating each cys-
teine residue in the primary sequence of
Hala and Halb to an alanine, they could
prevent the formation of a specific thio-
ether ring. In Hala, it was found that thio-
ether ring B is not necessary for bioactiv-
ity, whereas ring C is essential and ring A
is an important contributor. In Halb, ring A
did not play a key role in bioactivity; how-
ever, disturbing the formation of ring C
and D affected the activity significantly.
An important finding from this work dem-
onstrates that disrupting the formation of
ring B in Halb affects the formation of
other rings. Further investigations may re-
veal whether there is a preference for the
cyclization enzyme to act on conforma-
tionally-restricted substrates during for-
mation of other rings. Also, knowing that
ring A in Halb is not important for bioactiv-
ity may allow researchers to design sim-
pler analogs of Halb. The authors also
found that Glu22 in Hala is required for
biological activity. This position shows
sequence homology to mersacidin, sug-
gesting that this residue may have a
similar role in binding to lipid II. One could
ask whether this observation can be gen-
eralized to other lantibiotics, such as
lacticin 3147 A1, which has a Glu at posi-
tion 24.
A unique feature of Hala is the presence
of a N-terminal disulfide ring system. Coo-
per et al. (2008) have explored the role of
this ring and their results suggest that
this ring is not crucial for bioactivity. How-
ever, the authors claim that this ring
systemmay protect the peptide from pro-
teolytic cleavage by extracellular prote-
ases. If the N-terminal ring does indeed
serve such a function, it would be interest-
ing to explore if such rings in other lantibi-
otics also provide proteolytic stability.
Figure 1. Structures of Haloduracin, Hala and Halb
The thioether-linkage is highlighted in red.
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PreviewThis work by Cooper et al. (2008) ex-
plores the functions of posttranslational
modifications in lantibiotics by a combina-
tion of site-directed mutagenesis and
in vitro enzymatic transformation, a versa-
tile technique that can be extended to
other lantibiotics. Although it is generally
accepted that lanthionine rings and other
posttranslational modifications are impor-
tant for the mode of action of lantibiotics,
structure activity relationship studies are
needed to reveal the specific role of
each modification. From the findings by
Cooper et al. (2008), it is clear that not all
posttranslational modifications are re-
quired for bioactivity. However, they may
serve other key functions in stabilizing
the peptide. By eliminating the functional
moieties that do not interfere with the
mode of action, new lantibiotics may be
engineered or synthesized that retain bio-
activity but are structurally simpler. This
work offers a detailed evaluation of
a two-component lantibiotic system and
it opens the door for investigating the
structure-activity relationships of other
lantibiotics.
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